The petitioner later submitted a supplementary representation to the authorities concerned on July 13, 2025, along with supporting material.
However, it is alleged that no formal decision has been taken by the CDSCO within the three-month period prescribed by the Court. Only informal communications were made by CDSCO, indicating that the matter was “under consideration.” Reminder communications sent subsequently also did not result in any substantive response, the petitioner says.
The petitioner has, therefore, filed a contempt of court petition over this alleged failure by the CDSCO to tackle the misuse of such diabetes drugs.
The petitioner has contended that the failure to take a decision within the prescribed time amounts to non-compliance with the Court’s order.